EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer

2013139 citationsJournal Articlehybrid Open Access

Authors

Savas D. Soysal · University Hospital of Basel

Simone Muenst · Washington University in St. Louis

Thanh U. Barbie · Washington University in St. Louis

Timothy P. Fleming · Washington University in St. Louis

Feng Gao · Washington University in St. Louis

Gilbert Spizzo · Krankenhaus Meran

Daniel Oertli

Abstract

The differential association of EpCAM expression with prognosis in intrinsic subtypes has important implications for the development of EpCAM-targeted therapies in breast cancer.

Topics & Keywords

Cancer Cells and Metastasis HER2/EGFR in Cancer Research Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Cancer

Volume 108, Issue 7, pp. 1480-1487

DOI: 10.1038/bjc.2013.80

Field-Weighted Citation Impact: 3.61